stars 1 stars 2 stars 3

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.

View Top Employees from Immunomic Therapeutics, Inc.
Revenue $5 million
Funding $83.5 million
Employees 44 (44 on RocketReach)
Founded 2005
Address 15010 Broschart Road Suite 250, Rockville, Maryland 20850, US
Phone (301) 968-3501
JavaScript, HTML, PHP +19 more (view full list)
Category Biotechnology, DNA Vaccines, Pharmaceuticals, Science and Engineering, LAMP Technology, Healthcare, Life Science, Allergy, Therapeutics, Oncology, Health Care, Animal Health, Infectious Diseases
Competitors Altimmune, Inc., Angiochem, Mologen AG (MGN), Profectus BioSciences, Inc, Vaxart, Inc.
SIC SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies

Immunomic Therapeutics, Inc. Questions

The Immunomic Therapeutics, Inc. annual revenue was $5 million in 2024.

44 people are employed at Immunomic Therapeutics, Inc..

Immunomic Therapeutics, Inc. is based in Rockville, Maryland.

The NAICS codes for Immunomic Therapeutics, Inc. are [5417, 54, 541].

The SIC codes for Immunomic Therapeutics, Inc. are [283, 28].

Top Immunomic Therapeutics, Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users